BRYAN WIECK: Open Payments
NPI 1962401166 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 72 payments from 15 companies in 2025. Trend: 2023 $700 · 2024 $547 · 2025 $1,508
Food & beverage: $1,508
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $530 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $142 |
| Corium, LLC | 6 | $135 |
| Neurocrine BioSciences, Inc. | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 4 | $98 |
| ABBVIE INC. | 4 | $91 |
| Alkermes, Inc. | 4 | $84 |
| Lundbeck LLC | 3 | $64 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $42 |
Products named: REXULTI, CAPLYTA, Azstarys, INGREZZA, COBENFY, VRAYLAR, ARISTADA, Jornay PM.
Industry payments across TX — which companies pay providers there.
